NASDAQ: ABCL
Abcellera Biologics Inc Stock Ownership - Who owns Abcellera Biologics?

Insider buying vs selling

Have Abcellera Biologics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
John S. MontalbanoDirector2025-11-2650,000$3.57
$178.45kBuy
Thermopylae Holdings Ltd10% Owner2025-03-11343,631$2.16
$742.24kBuy
John S. MontalbanoDirector2025-03-1025,000$2.30
$57.50kBuy
John S. MontalbanoDirector2025-03-0660,000$2.34
$140.58kBuy

1 of 1

ABCL insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ABCL insiders and whales buy or sell their stock.

ABCL Shareholders

What type of owners hold Abcellera Biologics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Carl L. G. Hansen19.04%56,984,009$206.28MInsider
Thermopylae Holdings Ltd18.76%56,143,640$203.24MInsider
Baker Bros Advisors LP9.20%27,525,640$99.64MInstitution
John Hamer4.92%14,734,623$53.34MInsider
Capital World Investors4.46%13,361,096$48.37MInstitution
Baillie Gifford Co3.48%10,422,966$37.73MInstitution
Two Sigma Investments LP1.73%5,175,142$18.73MInstitution
Two Sigma Advisers LP1.60%4,799,900$17.38MInstitution
Arrowmark Colorado Holdings LLC1.37%4,105,095$14.86MInstitution
Blackrock Inc1.22%3,641,779$13.18MInstitution

1 of 3

ABCL vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ABCL34.75%44.54%Net BuyingNet Buying
PVLA57.88%42.12%Net BuyingNet Buying
MDXG46.43%53.57%Net BuyingNet Selling
SPRY44.43%55.57%Net SellingNet Selling
PHAT65.65%34.35%Net SellingNet Selling

Abcellera Biologics Stock Ownership FAQ

Who owns Abcellera Biologics?

Abcellera Biologics (NASDAQ: ABCL) is owned by 34.75% institutional shareholders, 44.54% Abcellera Biologics insiders, and 20.70% retail investors. Carl L. G. Hansen is the largest individual Abcellera Biologics shareholder, owning 56.98M shares representing 19.04% of the company. Carl L. G. Hansen's Abcellera Biologics shares are currently valued at $200.01M.

If you're new to stock investing, here's how to buy Abcellera Biologics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.